Send mail to Author

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __   __   __   _____       ___     _____       ___    
 | |/ //  \ \\/ // |  __ \\    / _ \\  |  __ \\    / _ \\  
 | ' //    \ ` //  | |  \ ||  | / \ || | |  \ ||  | / \ || 
 | . \\     | ||   | |__/ ||  | \_/ || | |__/ ||  | \_/ || 
 |_|\_\\    |_||   |_____//    \___//  |_____//    \___//  
 `-` --`    `-`'    -----`     `---`    -----`     `---`
 


Back to frontdoor view

OPUS4 Logo